Regulatory News
Thursday, January 19, 2017
UPDATE 1-U.S. health agency tells Grassley there is no EpiPen deal yet
NEW YORK, Jan 19 (Reuters) - Mylan NV has yet to
reach a settlement with the U.S. Department of Justice over the
classification in the Medicaid program of its life-saving EpiPen
allergy treatment,...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment